Linde India Ltd
NSE: LINDEINDIA BSE: 523457Infra
Linde India Limited, a subsidiary of BOC Group,UK (owns 75% stake in the co), is primarily engaged in manufacture of industrial and medical gases and construction of cryogenic and non cryogenic air separation plants.[1]
₹7,208
52W: ₹5653 — ₹8049
PE 105 · Book ₹463 · +1457% vs bookMarket Cap₹61,470 Cr
Stock P/E105Price to Earnings
ROCE16.9%Return on Capital
ROE12.3%Return on Equity
Div. Yield0.06%Face Value ₹10
Strengths
- +Company is almost debt free.
- +Company has been maintaining a healthy dividend payout of 22.0%
Weaknesses
- −Stock is trading at 15.6 times its book value
- −The company has delivered a poor sales growth of 7.12% over past five years.
Shareholding Pattern
Promoters75%
FIIs2.05%
DIIs6.88%
Public16.08%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% |
| FIIs | 3.03% | 2.42%▼0.6 | 2.27%▼0.1 | 2.63%▲0.4 | 2.51%▼0.1 | 2.35%▼0.2 | 2.03%▼0.3 | 2.05%▲0.0 |
| DIIs | 6.84% | 6.88%▲0.0 | 6.81%▼0.1 | 6.49%▼0.3 | 6.62%▲0.1 | 6.75%▲0.1 | 6.95%▲0.2 | 6.88%▼0.1 |
| Public | 15.13% | 15.7%▲0.6 | 15.92%▲0.2 | 15.9%▼0.0 | 15.87%▼0.0 | 15.9%▲0.0 | 16.02%▲0.1 | 16.08%▲0.1 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 711 | 706 | 630 | 653 | 634 | 606 | 592 | 571 | 644 | 701 |
| Expenses | 538 | 520 | 452 | 469 | 456 | 414 | 382 | 374 | 362 | 444 |
| Operating Profit | 174 | 186 | 179 | 184 | 179 | 192 | 210 | 197 | 282 | 257 |
| OPM % | 24% | 26% | 28% | 28% | 28% | 32% | 35% | 34% | 44% | 37% |
| Net Profit | 107 | 117 | 104 | 112 | 104 | 114 | 118 | 105 | 169 | 192 |
| EPS ₹ | 12.51 | 13.74 | 12.23 | 13.08 | 12.24 | 13.37 | 13.82 | 12.32 | 19.82 | 22.46 |
AI Insights
Revenue Trend
TTM revenue at ₹2,508Cr, up 0.9% YoY. OPM at 38%.
Debt Position
Borrowings at ₹67Cr. Debt-to-equity ratio: 0.02x. Healthy balance sheet.
Capex Cycle
CWIP at ₹1,266Cr (65% of fixed assets). Significant capex underway — growth runway building.
Institutional Flow
DIIs: 6.88% (-0.88pp change). FIIs: 2.05% (-0.80pp change). Promoters hold 75%.
Margin & Efficiency
ROCE improving from 5% (Dec 2013) to 17% (Mar 2025). Working capital days: -29.
Valuation
PE 105x with 16.9% ROCE. Price is 1457% above book value of ₹463. Dividend yield: 0.06%.
Recent Announcements
- Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended 31 March 2026 2d - Board meets 30 May 2026 to approve FY26 audited results and consider dividend.
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 28 Apr - Linde India says it is not a SEBI-defined large corporate; initial disclosure filed on 28 April 2026.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 15 Apr - Our letter no. Sect/32 dated 15th April 2026 with respect to certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. You are …
- Minutes Of Extra-Ordinary General Meeting Of The Company Held Through Video Conference/Other Audio-Visual Means On Thursday, 5Th March 2026 3 Apr - EGM minutes: material RPT approval for Praxair India worth Rs 4,177 million for FY2025-26 was not passed.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 27 Mar - Our letter no. Sect/27 dated 27th March 2026 enclosing therewith copies of newspaper publications regarding public notice for transfer of shares to the IEPF Authority. …
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse